Article Details

Oppenheimer Weighs in on Viking Therapeutics, Inc.'s Q1 2021 Earnings (NASDAQ:VKTX)

Retrieved on: 2021-02-19 11:26:15

Tags for this article:

Click the tags to see associated articles and topics

Oppenheimer Weighs in on Viking Therapeutics, Inc.'s Q1 2021 Earnings (NASDAQ:VKTX). View article details on hiswai:

Excerpt

BlackRock Inc. now owns 5,316,337 shares of the biotechnology company's stock valued at $29,931,000 after acquiring an additional 605,585 shares ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo